DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Ana Osório(Spanish National Cancer Research Centre), Anne‐Marie Gerdes(Copenhagen University Hospital), Guillermo Pita(Spanish National Cancer Research Centre), Karoline Kuchenbaecker(University of Cambridge), Elizabeth J. van Rensburg(University of Pretoria), Banu Arun(The University of Texas Health Science Center at Houston), Teresa Ramón y Cajal(Hospital de Sant Pau), John L. Hopper(The University of Melbourne), Tereza Vaclová(Spanish National Cancer Research Centre), Thomas van Overeem Hansen(University of Copenhagen), Hans Ehrencrona(Lund University), Alice S. Whittemore(Cancer Registry of Norway), Roger L. Milne(The University of Melbourne), Daniel Barrowdale(University of Cambridge), Esther M. John, Yuan Chun Ding(University of Copenhagen), Irene Konstantopoulou(National Centre of Scientific Research "Demokritos"), Christine Walsh(Cedars-Sinai Medical Center), Olufunmilayo I. Olopade(University of Chicago), Ramūnas Janavičius(Vilnius University), Susan L. Neuhausen(City of Hope), Mary Beth Terry(Columbia University Irving Medical Center), Susan M. Domchek(University City Science Center), Katherine L. Nathanson(Translational Therapeutics (United States)), Linda Steele(University of Technology Sydney), Saundra S. Buys(University of Utah), Ignacio Blanco(Hospital Universitari Germans Trias i Pujol), Cristina Martínez-Bouzas(Hospital Clínico Universitario Lozano Blesa), Beth Y. Karlan(University of California, Los Angeles), M. Durán(Universidad de Valladolid), Melissa C. Southey(The University of Melbourne), Andrew Lee(University of Cambridge), Cecilia M. Dorfling(QIMR Berghofer Medical Research Institute), Brita Arver(Karolinska University Hospital), Paolo Peterlongo(IFOM), Lesley McGuffog(University of Cambridge), Lars Jønson(Copenhagen University Hospital), Mary B. Daly(Fox Chase Cancer Center), Jenny Lester(Cedars-Sinai Medical Center), Johanna Rantala(Karolinska University Hospital), Timothy R. Rebbeck(University of Pennsylvania), Bent Ejlertsen(Copenhagen University Hospital), Mary Beattie, Niklas Loman(Lund University), Raquel Andrés Conejero(Centre hospitalier universitaire de Québec), Orland Dı́ez(Vall d'Hebron Hospital Universitari), Penny Soucy(University of Cambridge), Rosario Alonso(Spanish National Cancer Research Centre)
Cited by 130
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k